Login

Ben McMillan, CIO of IDX Digital Assets, discusses this week's crypto market volatility and its potential implications. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
August 2024 Market Insights with Argonaut Capital: “Fighting The Fed”
00:10:00
Ville Kangasmuukko Reflects on Bubbleroom's Strategic Adjustments During the Pandemic | Ville Kangasmuukko, CEO, New Bubbleroom Sweden AB.
00:10:00
Amper Technologies | Process & Approach | Akshat Thirani, CEO, Amper SAAPR:MUN
00:10:00
Empowering Tomorrow: Dynex Semiconductor's Journey | Clive Vacher ,President and CEO of Dynex Power Inc
00:10:00
King River Resources: Leading Vanadium and Gold Exploration in Australia's Kimberley Region
00:10:00
AbitareIn Ventures into Rental Market with Homizy: Insights from CEO Marco Grillo | Marco Claudio Grillo, CEO , Abitare In SpA.
00:10:00
Interview with Bob Kipps on GovCon M&A Trends
00:10:00
Investing in immigrant founders|Manan Mehta,Founding Partner,Unshackled Ventures
00:10:00
Danielle Xandra's Monthly Green Polka Dot Box Unboxing: Healthy Finds and Natural Products
00:10:00
Sovereign investor managing a global portfolio|Khaldoon Al Mubarak,Managing Director and Group CEO,Mubadala
00:10:00
Automotive 2025: Global Trends and Their Impact on Lubricants | William Downey - Partner, Roland Berger
00:10:00
Hydrogen's Role in Decarbonization: Creating Jobs and Enhancing Renewable Energy

© 2017 - Neuhu+